XML 33 R50.htm IDEA: XBRL DOCUMENT v2.4.1.9
Acquisitions and License Agreements (Schedule of Unaudited Pro Forma Information) (Details) (Questcor and Cadence Pharmaceuticals, USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended
Dec. 27, 2013
Questcor and Cadence Pharmaceuticals
 
Business Acquisition, Pro Forma Information [Line Items]  
Net sales, pro forma $ 818.4us-gaap_BusinessAcquisitionsProFormaRevenue
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember
Net (loss) income, pro forma $ 61.2us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember
Basic (loss) earnings per share, pro forma (in usd per share) $ 0.54us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember
Diluted (loss) earnings per share, pro forma (in usd per share) $ 0.53us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted
/ us-gaap_BusinessAcquisitionAxis
= mnk_QuestcorAndCadencePharmaceuticalsMember